In Vitro Activities against Cystic Fibrosis Pathogens of Synthetic Host Defence Propeptides Processed by Neutrophil Elastase.
Authors
Desgranges, StephaneLe Prieult, Florie
Daly, Alan
Lydon, Jennifer
Brennan, Marian
Rai, Dilip K
Subasinghage, Anusha P
Hewage, Chandralal M
Cryan, Sally-Ann
Greene, Catherine
McElvaney, Noel G
Smyth, Timothy P
Fitzgerald-Hughes, Deirdre
Humphreys, Hilary
Devocelle, Marc
Affiliation
Centre for Synthesis and Chemical Biology, Department of Pharmaceutical & Medicinal Chemistry, Royal College of Surgeons in Ireland, 123, St. Stephen's Green, Dublin 2; Department of Clinical Microbiology, Royal College of Surgeons in Ireland, Dublin 9; Department of Microbiology, Beaumont Hospital, Dublin 9; Molecular & Cellular Therapeutics, Royal College of Surgeons in Ireland, 123, St. Stephen's Green, Dublin 2; School of Biomolecular and Biomedical Science, Centre for Synthesis and Chemical Biology, Conway Institute, University College Dublin, Belfield, Dublin 4; School of Pharmacy, Royal College of Surgeons in Ireland, 123, St. Stephen's Green, Dublin 2; Department of Respiratory Research, Royal College of Surgeons in Ireland, Beaumont Hospital, Dublin 9; and Department of Chemical & Environmental Sciences, University of Limerick, Ireland.Issue Date
2011-02-22
Metadata
Show full item recordCitation
In Vitro Activities against Cystic Fibrosis Pathogens of Synthetic Host Defence Propeptides Processed by Neutrophil Elastase. 2011:notAntimicrob Agents ChemotherJournal
Antimicrobial agents and chemotherapyDOI
10.1128/AAC.01384-10PubMed ID
21343449Abstract
The antimicrobial and haemolytic activities of a host defence peptide can be controlled by modification as a propeptide of reduced net charge which can be processed by neutrophil elastase, a serine protease involved in chronic airway inflammation and infections associated with cystic fibrosis.Item Type
Article in PressLanguage
nullISSN
1098-6596ae974a485f413a2113503eed53cd6c53
10.1128/AAC.01384-10